Hyphens Pharma 1J5
Dividend history
Recorded rates may be provisional. Annual yields use today's price; they are not historical investment returns.
2026 year to date 1 record Yield at current price4.29% Annual dividend per shareSGD 0.015
| Amount | Ex Date | Pay Date | Particulars / source |
|---|---|---|---|
| SGD 0.015 |
2025 1 record Yield at current price4.29% Annual dividend per shareSGD 0.015
| Amount | Ex Date | Pay Date | Particulars / source |
|---|---|---|---|
| SGD 0.015 |
2024 1 record Yield at current price2.46% Annual dividend per shareSGD 0.0086
| Amount | Ex Date | Pay Date | Particulars / source |
|---|---|---|---|
| SGD 0.0086 |
2023 2 records Yield at current price13.46% Annual dividend per shareSGD 0.0471
| Amount | Ex Date | Pay Date | Particulars / source |
|---|---|---|---|
| SGD 0.036 | |||
| SGD 0.0111 |
2022 1 record Yield at current price1.91% Annual dividend per shareSGD 0.0067
| Amount | Ex Date | Pay Date | Particulars / source |
|---|---|---|---|
| SGD 0.0067 |
Annual totals, currencies and data coverage
Spot an error? Let us know.
Annual dividend per share is the calendar-year cash total, converted to the share-price currency using available exchange rates. Yield is that total divided by today's share price; it is not the historical investment return.
The current year is marked year to date. Its total includes ex-dates through today; future rows remain visible but are excluded. Amounts with missing data are unavailable, not zero.
Possible duplicate source records are shown together and can be expanded. Different confirmed references remain separate. Totals under review are withheld until the source identity is verified.
Free view: the latest five calendar years. Corporate-action dates are displayed as published; time-based summaries use SGT.
Background
Annual Report 2025 · Reviewed 2026-10-23 · Source dated 2026-04-10 · PDF p. 5
Hyphens Pharma International is a Singapore-based pharmaceutical and consumer healthcare group serving ASEAN and other markets. Its businesses connect healthcare products and pharmaceutical innovations with regional customers through its network of operating entities.